Researchers develop Band-Aid sized ultrasound scanner

University of British Columbia (UBC) engineers have created a new ultrasound machine that’s reportedly “no bigger than a Band-Aid” and could lower the cost of ultrasound scanners to $100.

According to a press release, typical ultrasound machines use piezoelectric crystals to create images and send them to a computer to create sonograms. Engineers created the ultrasound machine by replacing piezoelectric crystals with tiny, vibrating drums made of polymer resin.

With the drums being cheaper to manufacture than the crystals and by using a minimum amount of equipment, engineers said they saw a “significant cost savings” while creating the device. They also said the “sonograms produced by the UBC device were as sharp as or even more detailed than traditional sonograms produced by piezoelectric transducers.”

Engineers also said the new ultrasound machine as is “no bigger than a Band-Aid,” portable, wearable and can be powered by a smartphone. A patent is pending for the device. Engineers also hope to create more prototypes and test the device in clinical applications, the release stated. 

“You could miniaturize these transducers and use them to look inside your arteries and veins. You could stick them on your chest and do live continuous monitoring of your heart in your daily life. It opens up so many different possibilities,” UBC professor Robert Rohling said in a statement.

""

Danielle covers Clinical Innovation & Technology as a senior news writer for TriMed Media. Previously, she worked as a news reporter in northeast Missouri and earned a journalism degree from the University of Illinois at Urbana-Champaign. She's also a huge fan of the Chicago Cubs, Bears and Bulls. 

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.